(Q27824835)

English

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

scientific article

Statements

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group (English)
1 reference
0 references
0 references
0 references
Michel Marty
0 references
Francesco Cognetti
0 references
Dominique Maraninchi
0 references
Ray Snyder
0 references
Louis Mauriac
0 references
Michèle Tubiana-Hulin
0 references
Stephen Chan
0 references
Antonio Antón
0 references
Ana Lluch
0 references
John Kennedy
0 references
Kenneth O'Byrne
0 references
Michael Green
0 references
Carol Ward
0 references
Karen Mayne
0 references
Jean-Marc Extra
0 references
1 July 2005
0 references
23
0 references
4265-74
0 references
19
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit